SurModics (SRDX) Tops Q2 EPS by 11c

Go back to SurModics (SRDX) Tops Q2 EPS by 11c

SurModics Reports Second Quarter Fiscal 2016 Results

May 2, 2016 4:50 PM EDT

GAAP Revenue of $16.7 Million, up 16%, Third Consecutive Quarter of Double-Digit Growth GAAP EPS of $0.06, Non-GAAP EPS of $0.20 SurVeil Drug-Coated Balloon Commences IDE Study Raises Revenue and Non-GAAP EPS Guidance Ranges

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- SurModics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2016 second quarter, ended March 31, 2016.

For the third consecutive quarter, we... More

SurModics to Webcast Second Quarter 2016 Earnings Conference Call on May 2

April 28, 2016 7:05 PM EDT

Webcast is Live at 4 p.m. (CT)

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- SurModics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its second quarter fiscal 2016 conference call on Monday, May 2, at 4 p.m. CT (5 p.m. ET). The Company will issue an earnings news release after the market closes that afternoon.

Gary Maharaj, president and chief executive officer, and Andy LaFrence, vice president of finance... More